The Effect of High-Dose Intravenous N-Acetylcysteine Administration on Tumor Necrosis Factor-α (TNF)

Sahrun Sahrun

doi:10.37287/ijghr.v6i6.3764

Sahrun Sahrun Faculty of Medicine, Universitas Al Azhar Mataram

DOI: https://doi.org/10.37287/ijghr.v6i6.3764

Keywords: cap, N Acetylcysteine, pneumonia, tumor necrosis factor-α

Abstract

Respiratory tract infections are among the five most common health problems worldwide, with pneumonia being a significant contributor. Pneumonia continuously increases the rates of morbidity and mortality globally. Pneumonia is classified into three categories, one of which is Community Acquired Pneumonia (CAP). The incidence of community-acquired pneumonia increases with age. The risk of death from pneumonia also increases in individuals over 65 years old and those with comorbidities.The objective of this study is to assess the impact of high-dose intravenous N-acetylcysteine on the clinical improvement of inflammatory markers (TNF-α) among hospitalized CAP patients with comorbidities.Methods: This study is a randomized controlled trial. The sample population comprises patients with respiratory diseases hospitalized at RS Patut Patuh Patju (Tripat) Gerung. The sample size was obtained through total sampling during the period from January to May 2022, ranging from 10 to 25 patients per month, with an average of 15 patients per month. The dependent variable in this study is CAP with comorbidities, while the independent variable is the clinical improvement of inflammatory markers. Data analysis between variables was performed using a t-test for two means. The aim of this study is to assess the effect of clinical improvement in inflammatory markers (TNF-α) in hospitalized CAP patients with comorbidities after the administration of high-dose intravenous N Acetylcysteine. The mean value of Tumor Necrosis Factor-α before the intervention was 77.699, and the post-test mean value was 41.137. The analysis of the paired t-test for Tumor Necrosis Factor-α showed a P value of 0.000 <α=0.05. The Mann-Whitney test used to assess the difference in Tumor Necrosis Factor-α between the Intervention and control groups after N-Acetylcysteine therapy revealed a P value of 0.000 <α=0.05. The conclusion of this study is that there is an effect of high-dose intravenous N Acetylcysteine on Tumor Necrosis Factor-α, and there is a significant difference in the change in Tumor Necrosis Factor-α between the Intervention and control groups.

References

Afriani, R., & Maulina, D. (2023). Gambaran Penggunaan N-Acetyl-L-Cysteine (NAC) Pada Pasien Covid-19 Di RS X Periode Juni-Agustus 2022. Indonesian Journal of Health Science, 3(1), 60–68. https://doi.org/10.54957/ijhs.v3i1.422

Brodier, E. A., Raithatha, M., Kannan, S., & Karunasekara, N. (2019). Use of nebulised N-acetylcysteine as a life-saving mucolytic in intensive care: A case report. Journal of the Intensive Care Society, 21(4), 296–298. https://doi.org/10.1177/1751143719870089

Bryan, A., Pingali, P., Joslyn, M., Li, H., Bernas, T., Koblinski, J., Joseph Landry 5, W. S. L. 1, & , Bhaumik Patel 1, 6 and Alexander Neuwelt. (2023). High dose acetaminophen with n-acetylcysteine rescue inhibits M2 polarization of tumor associated macrophages. Cancer Research, 83(7_Supplement), 6388. https://doi.org/10.1158/1538-7445.AM2023-6388

El Hamamsy, M., Bondok, R., Shaheen, S., & Eladly, G. H. (2019). Safety and efficacy of adding intravenous N-acetylcysteine to parenteral L-alanyl-L-glutamine in hospitalized patients undergoing surgery of the colon: A randomized controlled trial. Annals of Saudi Medicine, 39(4), 251–257. https://doi.org/10.5144/0256-4947.2019.251

Fallah, M., Moghble, N., Javadi, I., Bahadoran, H., & Shahriary, A. (2018). Effect of curcumin and n-acetylcysteine on brain histology and inflammatory factors (MMP-2, 9 and TNF-α) in rats exposed to arsenic. Pharmaceutical Sciences, 24(4), 264–272. https://doi.org/10.15171/PS.2018.39

Franquet, T. (2018). Imaging of Community-acquired Pneumonia. Journal of Thoracic Imaging, 33(5). https://journals.lww.com/thoracicimaging/fulltext/2018/09000/imaging_of_community_acquired_pneumonia.3.aspx

Freitas, M. O., De Queiroz Rodrigues, M. I., De Lima Martins, J. O., De Aguiar, M. T., Da Silva, P. M. F., De Barros Silva, P. G., & Alves, A. P. N. N. (2022). TUMOR NECROSIS FACTOR (TNF)-α PLAYS A ROLE IN ORAL ULCERATION IN RATS. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 134(3), e198. https://doi.org/https://doi.org/10.1016/j.oooo.2022.01.606

Hallajzadeh, J., Milajerdi, A., Reiner, Ž., Kolahdooz, F., & Asemi, Z. (2020). The Effects of N-acetylcysteine on Inflammatory Markers and Homocysteine: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Pharmaceutical Sciences, 26(3), 214–224. https://doi.org/10.34172/PS.2020.30

Ibrahim, H., Perl, A., Smith, D., Lewis, T., Kon, Z., Goldenberg, R., Yarta, K., Staniloae, C., & Williams, M. (2020). Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine. Clinical Immunology, 219, 108544. https://doi.org/https://doi.org/10.1016/j.clim.2020.108544

Kemenkes RI. (2022). Profil Kesehatan Indonesia 2022.

Khatib, N., Weiner, Z., Ginsberg, Y., Awad, N., & Beloosesky, R. (2017). Protective Effect of N-Acetyl-Cysteine (NAC) in Lipopolysaccharide (LPS)-Associated Inflammatory Response in Rat Neonates. Rambam Maimonides Medical Journal, 8(2), e0026. https://doi.org/10.5041/rmmj.10303

Lank et al. (2019). Hospital-Acquired and Ventilator-Associated Pneumonia Quick Answers for Clinicians. 3, 1–5.

Larki, R. A., Panahi, A., Manzouri, L., & Sedaghattalab, M. (2019). Effect of N-acetylcysteine on inflammatory and biochemical markers of hemodialysis patients: A randomized controlled trial. Acta Medica Iranica, 57(1), 57–62. https://doi.org/10.18502/acta.v57i1.1754

Li, X., Wei, X., Chen, C., Zhang, Z., Liu, D., Hei, Z., & Yao, W. (2018). N-Acetylcysteine inhalation improves pulmonary function in patients received liver transplantation. Bioscience Reports, 38(5), 1–11. https://doi.org/10.1042/BSR20180858

Mokra, D., Mokry, J., Barosova, R., & Hanusrichterova, J. (2023). Advances in the Use of N-Acetylcysteine in Chronic Respiratory Diseases. Antioxidants, 12(9). https://doi.org/10.3390/antiox12091713

Neuwelt, A., Bryan, A., Lee, W., Pingali, P., Li, H., & Patel, B. (2023). Abstract 6388: High dose acetaminophen with n-acetylcysteine rescue inhibits M2 polarization of tumor associated macrophages. Cancer Research, 83(7_Supplement), 6388. https://doi.org/10.1158/1538-7445.AM2023-6388

Nursalam. (2021). Metodelogi penelitian (1st ed.). Gramedia.

PDPI. (2014). Pneumonia Komuniti: Pedoman diagnosis dan penatalaksanaan di Indonesia (III). Perhimpunan Dokter Paru Indonesia.

Poe, F. L., & Corn, J. (2020). N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2. Medical Hypotheses, 143(May), 16–19. https://doi.org/10.1016/j.mehy.2020.109862

Rahmanto, D. (2021). Pengaruh Pemberian Inhalasi N-Acetylcysteine Terhadap Kadar Tumor Necrosis Factor-a dan Cough Severity Score pada Pasien Pneumonia Komunitas. Sebelas Maret University.

Riskesdas NTB. (2018). Laporan Provinsi Nusa Tenggara Barat Riskesdas 2018. In Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan (Vol. 53, Issue 9).

Sakai, M., Yu, Z., Taniguchi, M., Picotin, R., Oyama, N., Stellwagen, D., Ono, C., Kikuchi, Y., Matsui, K., Nakanishi, M., Yoshii, H., Furuyashiki, T., Abe, T., & Tomita, H. (2023). N-Acetylcysteine Suppresses Microglial Inflammation and Induces Mortality Dose-Dependently via Tumor Necrosis Factor-α Signaling. International Journal of Molecular Sciences, 24(4). https://doi.org/10.3390/ijms24043798

Sakamoto, S., Muramatsu, Y., Satoh, K., Ishida, F., Kikuchi, N., Sano, G., Sugino, K., Isobe, K., Takai, Y., & Homma, S. (2015). Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: A case-control study. Respirology, 20(3), 445–452. https://doi.org/10.1111/resp.12477

Spinou, A., & Birring, S. S. (2014). An update on measurement and monitoring of cough: what are the important study endpoints? Journal of Thoracic Disease, 6(Suppl 7), S728-34. https://doi.org/10.3978/j.issn.2072-1439.2014.10.08

Sujana, K. S., & Maulida, M. (2021). Efektivitas N-Acetylsistein pada Pasien COVID-19. Cermin Dunia Kedokteran, 48(7), 416–418. https://doi.org/10.55175/cdk.v48i7.99

Talasaz, A. H., Khalili, H., Jenab, Y., Salarifar, M., Broumand, M. A., & Darabi, F. (2013). N-acetylcysteine effects on transforming growth factor-β and tumor necrosis factor-α serum levels as pro-fibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction. Drugs in R and D, 13(3), 199–205. https://doi.org/10.1007/s40268-013-0025-5

Tenório, M. C. D. S., Graciliano, N. G., Moura, F. A., de Oliveira, A. C. M., & Goulart, M. O. F. (2021). N-acetilcisteína (NAC): impactos en la salud humana. Antioxidants, 10(6).

Tieu, S., Karrow, N., Mallard, B., Bridle, B., Charch, A., & Wagter-Lesperance, L. (2022). N-Acetylcysteine (NAC) and its Immunomodulatory Properties: Part II. Mechanisms of action. SURG Journal, 14(1).

Zaka, M., Abbasi, B. H., & Durdagi, S. (2019). Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models. Journal of Biomolecular Structure & Dynamics, 37(9), 2464–2476. https://doi.org/10.1080/07391102.2018.1491423

Zhang, Q., Ju, Y., Ma, Y., & Wang, T. (2018). N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial. Medicine, 97(45). https://journals.lww.com/md-journal/fulltext/2018/11090/n_acetylcysteine_improves_oxidative_stress_and.35.aspx.